Report Detail

Request for Sample of this report

Other Global Covid-19 Treatment Market 2026 by Company, Regions, Type and Application, Forecast to 2032

  • RnM4668239
    • |
  • 22 January, 2026
    • |
  • Global
    • |
  • 127 Pages
    • |
  • GIR
    • |
  • Other

According to our (Global Info Research) latest study, the global Covid-19 Treatment market size was valued at US$ 755 million in 2025 and is forecast to a readjusted size of US$ 1.96 million by 2032 with a CAGR of -57.9% during review period.
Patients today have more treatment options in the battle against coronavirus disease.
In November 2020, the FDA granted emergency use authorization to two monoclonal antibody treatments (bamlanivimab, made by Eli Lilly; and a combination of casirivimab and imdevimab, made by Regeneron). Both treatments have been approved for non-hospitalized adults and children over age 12 with mild to moderate COVID-19 symptoms who are at risk for developing severe COVID-19 or being hospitalized for it. In these patients, the approved treatments can reduce the risk of hospitalization and emergency room visits. These therapies must be given intravenously (by IV) soon after developing symptoms.
The FDA has approved the antiviral drug Veklury (remdesivir) for adults and certain pediatric patients with COVID-19 who are sick enough to need hospitalization. Veklury should only be administered in a hospital or in a health care setting capable of providing acute care comparable to inpatient hospital care.
The Drugs for Covid-19: Dexamethasone, Tocilizumab, Remdesivir, Baricitinib in combination with remdesivir, Anticoagulation drugs ("blood thinners"), etc.
In August 2020, the FDA issued an emergency use authorization (EUA) for convalescent plasma in patients hospitalized with COVID-19.
In this report, we study all treatment method for Covid-19.
Global core covid-19 treatment manufacturers include Cadila Healthcare, Novartis etc.The top 2 companies hold a share about 30%.North America is the largest market, with a share about 47%, followed by Europe and Asia Pacific with the share about 30% and 9%.
This report is a detailed and comprehensive analysis for global Covid-19 Treatment market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by End User. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Covid-19 Treatment market size and forecasts, in consumption value ($ Million), 2021-2032
Global Covid-19 Treatment market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Covid-19 Treatment market size and forecasts, by Type and by End User, in consumption value ($ Million), 2021-2032
Global Covid-19 Treatment market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Covid-19 Treatment
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Covid-19 Treatment market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cadila Healthcare, Johnson & Johnson, ImmunoPrecise, Novartis, AstraZeneca, Cipla, AbbVie, Bayer, Regeneron Pharmaceuticals, Ascletis Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Covid-19 Treatment market is split by Type and by End User. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by End User. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Life Support
Antiviral Medicine
Antibody Treatments
Others
Market segment by End User
Children
Adult
Market segment by players, this report covers
Cadila Healthcare
Johnson & Johnson
ImmunoPrecise
Novartis
AstraZeneca
Cipla
AbbVie
Bayer
Regeneron Pharmaceuticals
Ascletis Pharma
GlaxoSmithKline
Gilead Sciences
Pharmstandard
Fujifilm Holdings
Zhejiang Hisun Pharmaceutical Co. Ltd
Roche
Sanofi
Pfizer
Eli Lilly
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Covid-19 Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Covid-19 Treatment, with revenue, gross margin, and global market share of Covid-19 Treatment from 2021 to 2026.
Chapter 3, the Covid-19 Treatment competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by End User, with consumption value and growth rate by Type, by End User, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Covid-19 Treatment market forecast, by regions, by Type and by End User, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Covid-19 Treatment.
Chapter 13, to describe Covid-19 Treatment research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Covid-19 Treatment by Type
    • 1.3.1 Overview: Global Covid-19 Treatment Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Covid-19 Treatment Consumption Value Market Share by Type in 2025
    • 1.3.3 Life Support
    • 1.3.4 Antiviral Medicine
    • 1.3.5 Antibody Treatments
    • 1.3.6 Others
  • 1.4 Global Covid-19 Treatment Market by End User
    • 1.4.1 Overview: Global Covid-19 Treatment Market Size by End User: 2021 Versus 2025 Versus 2032
    • 1.4.2 Children
    • 1.4.3 Adult
  • 1.5 Global Covid-19 Treatment Market Size & Forecast
  • 1.6 Global Covid-19 Treatment Market Size and Forecast by Region
    • 1.6.1 Global Covid-19 Treatment Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Covid-19 Treatment Market Size by Region, (2021-2032)
    • 1.6.3 North America Covid-19 Treatment Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Covid-19 Treatment Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Covid-19 Treatment Market Size and Prospect (2021-2032)
    • 1.6.6 South America Covid-19 Treatment Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Covid-19 Treatment Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Cadila Healthcare
    • 2.1.1 Cadila Healthcare Details
    • 2.1.2 Cadila Healthcare Major Business
    • 2.1.3 Cadila Healthcare Covid-19 Treatment Product and Solutions
    • 2.1.4 Cadila Healthcare Covid-19 Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Cadila Healthcare Recent Developments and Future Plans
  • 2.2 Johnson & Johnson
    • 2.2.1 Johnson & Johnson Details
    • 2.2.2 Johnson & Johnson Major Business
    • 2.2.3 Johnson & Johnson Covid-19 Treatment Product and Solutions
    • 2.2.4 Johnson & Johnson Covid-19 Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Johnson & Johnson Recent Developments and Future Plans
  • 2.3 ImmunoPrecise
    • 2.3.1 ImmunoPrecise Details
    • 2.3.2 ImmunoPrecise Major Business
    • 2.3.3 ImmunoPrecise Covid-19 Treatment Product and Solutions
    • 2.3.4 ImmunoPrecise Covid-19 Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 ImmunoPrecise Recent Developments and Future Plans
  • 2.4 Novartis
    • 2.4.1 Novartis Details
    • 2.4.2 Novartis Major Business
    • 2.4.3 Novartis Covid-19 Treatment Product and Solutions
    • 2.4.4 Novartis Covid-19 Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Novartis Recent Developments and Future Plans
  • 2.5 AstraZeneca
    • 2.5.1 AstraZeneca Details
    • 2.5.2 AstraZeneca Major Business
    • 2.5.3 AstraZeneca Covid-19 Treatment Product and Solutions
    • 2.5.4 AstraZeneca Covid-19 Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 AstraZeneca Recent Developments and Future Plans
  • 2.6 Cipla
    • 2.6.1 Cipla Details
    • 2.6.2 Cipla Major Business
    • 2.6.3 Cipla Covid-19 Treatment Product and Solutions
    • 2.6.4 Cipla Covid-19 Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Cipla Recent Developments and Future Plans
  • 2.7 AbbVie
    • 2.7.1 AbbVie Details
    • 2.7.2 AbbVie Major Business
    • 2.7.3 AbbVie Covid-19 Treatment Product and Solutions
    • 2.7.4 AbbVie Covid-19 Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 AbbVie Recent Developments and Future Plans
  • 2.8 Bayer
    • 2.8.1 Bayer Details
    • 2.8.2 Bayer Major Business
    • 2.8.3 Bayer Covid-19 Treatment Product and Solutions
    • 2.8.4 Bayer Covid-19 Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Bayer Recent Developments and Future Plans
  • 2.9 Regeneron Pharmaceuticals
    • 2.9.1 Regeneron Pharmaceuticals Details
    • 2.9.2 Regeneron Pharmaceuticals Major Business
    • 2.9.3 Regeneron Pharmaceuticals Covid-19 Treatment Product and Solutions
    • 2.9.4 Regeneron Pharmaceuticals Covid-19 Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Regeneron Pharmaceuticals Recent Developments and Future Plans
  • 2.10 Ascletis Pharma
    • 2.10.1 Ascletis Pharma Details
    • 2.10.2 Ascletis Pharma Major Business
    • 2.10.3 Ascletis Pharma Covid-19 Treatment Product and Solutions
    • 2.10.4 Ascletis Pharma Covid-19 Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Ascletis Pharma Recent Developments and Future Plans
  • 2.11 GlaxoSmithKline
    • 2.11.1 GlaxoSmithKline Details
    • 2.11.2 GlaxoSmithKline Major Business
    • 2.11.3 GlaxoSmithKline Covid-19 Treatment Product and Solutions
    • 2.11.4 GlaxoSmithKline Covid-19 Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 GlaxoSmithKline Recent Developments and Future Plans
  • 2.12 Gilead Sciences
    • 2.12.1 Gilead Sciences Details
    • 2.12.2 Gilead Sciences Major Business
    • 2.12.3 Gilead Sciences Covid-19 Treatment Product and Solutions
    • 2.12.4 Gilead Sciences Covid-19 Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Gilead Sciences Recent Developments and Future Plans
  • 2.13 Pharmstandard
    • 2.13.1 Pharmstandard Details
    • 2.13.2 Pharmstandard Major Business
    • 2.13.3 Pharmstandard Covid-19 Treatment Product and Solutions
    • 2.13.4 Pharmstandard Covid-19 Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Pharmstandard Recent Developments and Future Plans
  • 2.14 Fujifilm Holdings
    • 2.14.1 Fujifilm Holdings Details
    • 2.14.2 Fujifilm Holdings Major Business
    • 2.14.3 Fujifilm Holdings Covid-19 Treatment Product and Solutions
    • 2.14.4 Fujifilm Holdings Covid-19 Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Fujifilm Holdings Recent Developments and Future Plans
  • 2.15 Zhejiang Hisun Pharmaceutical Co. Ltd
    • 2.15.1 Zhejiang Hisun Pharmaceutical Co. Ltd Details
    • 2.15.2 Zhejiang Hisun Pharmaceutical Co. Ltd Major Business
    • 2.15.3 Zhejiang Hisun Pharmaceutical Co. Ltd Covid-19 Treatment Product and Solutions
    • 2.15.4 Zhejiang Hisun Pharmaceutical Co. Ltd Covid-19 Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Zhejiang Hisun Pharmaceutical Co. Ltd Recent Developments and Future Plans
  • 2.16 Roche
    • 2.16.1 Roche Details
    • 2.16.2 Roche Major Business
    • 2.16.3 Roche Covid-19 Treatment Product and Solutions
    • 2.16.4 Roche Covid-19 Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 Roche Recent Developments and Future Plans
  • 2.17 Sanofi
    • 2.17.1 Sanofi Details
    • 2.17.2 Sanofi Major Business
    • 2.17.3 Sanofi Covid-19 Treatment Product and Solutions
    • 2.17.4 Sanofi Covid-19 Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 Sanofi Recent Developments and Future Plans
  • 2.18 Pfizer
    • 2.18.1 Pfizer Details
    • 2.18.2 Pfizer Major Business
    • 2.18.3 Pfizer Covid-19 Treatment Product and Solutions
    • 2.18.4 Pfizer Covid-19 Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.18.5 Pfizer Recent Developments and Future Plans
  • 2.19 Eli Lilly
    • 2.19.1 Eli Lilly Details
    • 2.19.2 Eli Lilly Major Business
    • 2.19.3 Eli Lilly Covid-19 Treatment Product and Solutions
    • 2.19.4 Eli Lilly Covid-19 Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.19.5 Eli Lilly Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Covid-19 Treatment Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Covid-19 Treatment by Company Revenue
    • 3.2.2 Top 3 Covid-19 Treatment Players Market Share in 2025
    • 3.2.3 Top 6 Covid-19 Treatment Players Market Share in 2025
  • 3.3 Covid-19 Treatment Market: Overall Company Footprint Analysis
    • 3.3.1 Covid-19 Treatment Market: Region Footprint
    • 3.3.2 Covid-19 Treatment Market: Company Product Type Footprint
    • 3.3.3 Covid-19 Treatment Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Covid-19 Treatment Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Covid-19 Treatment Market Forecast by Type (2027-2032)

5 Market Size Segment by End User

  • 5.1 Global Covid-19 Treatment Consumption Value Market Share by End User (2021-2026)
  • 5.2 Global Covid-19 Treatment Market Forecast by End User (2027-2032)

6 North America

  • 6.1 North America Covid-19 Treatment Consumption Value by Type (2021-2032)
  • 6.2 North America Covid-19 Treatment Market Size by End User (2021-2032)
  • 6.3 North America Covid-19 Treatment Market Size by Country
    • 6.3.1 North America Covid-19 Treatment Consumption Value by Country (2021-2032)
    • 6.3.2 United States Covid-19 Treatment Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Covid-19 Treatment Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Covid-19 Treatment Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Covid-19 Treatment Consumption Value by Type (2021-2032)
  • 7.2 Europe Covid-19 Treatment Consumption Value by End User (2021-2032)
  • 7.3 Europe Covid-19 Treatment Market Size by Country
    • 7.3.1 Europe Covid-19 Treatment Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Covid-19 Treatment Market Size and Forecast (2021-2032)
    • 7.3.3 France Covid-19 Treatment Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Covid-19 Treatment Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Covid-19 Treatment Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Covid-19 Treatment Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Covid-19 Treatment Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Covid-19 Treatment Consumption Value by End User (2021-2032)
  • 8.3 Asia-Pacific Covid-19 Treatment Market Size by Region
    • 8.3.1 Asia-Pacific Covid-19 Treatment Consumption Value by Region (2021-2032)
    • 8.3.2 China Covid-19 Treatment Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Covid-19 Treatment Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Covid-19 Treatment Market Size and Forecast (2021-2032)
    • 8.3.5 India Covid-19 Treatment Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Covid-19 Treatment Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Covid-19 Treatment Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Covid-19 Treatment Consumption Value by Type (2021-2032)
  • 9.2 South America Covid-19 Treatment Consumption Value by End User (2021-2032)
  • 9.3 South America Covid-19 Treatment Market Size by Country
    • 9.3.1 South America Covid-19 Treatment Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Covid-19 Treatment Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Covid-19 Treatment Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Covid-19 Treatment Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Covid-19 Treatment Consumption Value by End User (2021-2032)
  • 10.3 Middle East & Africa Covid-19 Treatment Market Size by Country
    • 10.3.1 Middle East & Africa Covid-19 Treatment Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Covid-19 Treatment Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Covid-19 Treatment Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Covid-19 Treatment Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Covid-19 Treatment Market Drivers
  • 11.2 Covid-19 Treatment Market Restraints
  • 11.3 Covid-19 Treatment Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Covid-19 Treatment Industry Chain
  • 12.2 Covid-19 Treatment Upstream Analysis
  • 12.3 Covid-19 Treatment Midstream Analysis
  • 12.4 Covid-19 Treatment Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Covid-19 Treatment. Industry analysis & Market Report on Covid-19 Treatment is a syndicated market report, published as Global Covid-19 Treatment Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Covid-19 Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo